CAP cells produce high virus titers upon influenza infection: Cevec Pharma
Cevec Pharma also added that the virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine

Cevec Pharma also added that the virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine

Onko-Sure is a simple, non-invasive, patent-pending and regulatory-approved in-vitro diagnostic test for the monitoring of colorectal cancer and for lung cancer detection and treatment monitoring by measuring the

Xerclear, a patented combination of 5% acyclovir and 1% hydrocortisone in Medivir’s proprietary cream formulation, is a topical product for the treatment of recurrent herpes labialis. As per

The agreement was signed by the companies to evaluate the replication of an undisclosed virus in Vivalis’ EB66 cell line for the manufacturing of human vaccines developed by

Before joining the company, Guggenhime served as senior vice president and CFO of at Facet Biotech and as PDL BioPharma as senior vice president and CFO. During his

Schniepp is expected to take up the responsibility for cGMP compliance of OsoBio’s facility. Additionally, quality-related matters concerning validation as well as regulatory affairs, records and filings fall

Intercept is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in

The increase in sales revenue resulted from the increase of the company’s sales volume and selling prices. Net profit for fiscal 2010 was $3.2m or 0.17 per share

The company has posted a net loss of $413,864 for the year ended 30 June 2010, or $ 0.06 loss per diluted share, compared to net loss of

As per the terms of the collaboration, BAC developed CaptureSelect custom affinity ligands for use in monitoring Genmab UniBody drug candidates in preclinical studies and clinical trials, and